GC Pharma (006280):製薬・医療:M&Aディール及び事業提携情報

GlobalDataが発行した調査報告書(DATA904C10135)
◆英語タイトル:GC Pharma (006280) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10135
◆発行会社(リサーチ会社):GlobalData
◆発行日:2018年11月
◆ページ数:43
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:韓国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥26,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥53,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥79,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。

【レポートの概要】

Summary
GC Pharma(GC Pharma) formerly known as Green Cross Corp, a subsidiary of Green Cross Holdings Corp provides plasma protein therapeutics and vaccines. The company develops, manufactures and markets a wide product portfolio comprising plasma derivatives including albumin, immunoglobulin, and antithrombin; vaccines for infectious diseases; prescription drugs for treating cardiovascular, respiratory, central nervous system (CNS), gastrointestinal and immunology diseases, musculoskeletal disorders, genetic disorders, metabolic disorders and hematological disorders; and Over-the-counter (OTC) drugs including anti-inflammatory drugs, anti-allergic products and others. The company focuses its research and development activities at developing pharmaceuticals for difficult to treat diseases, including cancer. GC Pharma is headquartered Yongin-si, Gyeonggi-do, South Korea.

GC Pharma (006280) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
GC Pharma, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
GC Pharma, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
GC Pharma, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
GC Pharma, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
GC Pharma, Medical Devices Deals, 2012 to YTD 2018 10
GC Pharma, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
GC Pharma, Pharmaceuticals & Healthcare, Deal Details 13
Venture Financing 13
Argos Therapeutics Raises US$60 Million In Series E Financing 13
Partnerships 16
Yuhan to Enter into Agreement with GC Pharma 16
Feldan Therapeutics and Green Cross LabCell Enter into Research Partnership 17
AroCell Enters into Co-Development Agreement with Green Cross Cell 18
Green Cross Cell Forms Joint Venture with Harbin Hou pu Tong tang Biotech 19
Green Cross Cell and ToolGen to Enter into Partnership 20
OGD2 Pharma Enters into Agreement with Green Cross LabCell 21
Oxford BioMedica Enters into Agreement with Green Cross 22
Green Cross Enters into Commercialization Agreement with Nanolek 23
Aquavit Pharma Announces Co-Development Agreement With Green Cross For IBX-001 24
Licensing Agreements 25
Lee’s Pharma Enters into Licensing Agreement with GC Pharma 25
Green Cross Enters into Licensing Agreement with Argos Therapeutics 26
Equity Offering 28
Green Cross LabCell Prices IPO of Shares for USD32 Million 28
Innocell Completes Private Placement Of Shares For US$13 Million 29
Debt Offering 30
Green Cross Cell Raises USD55.3 Million in Private Placement of Convertible Bonds 30
Acquisition 31
Green Cross Acquires Additional 7.07% Stake In Ildong Pharma From WhanIn Pharma 31
GC Pharma – Key Competitors 32
GC Pharma – Key Employees 33
GC Pharma – Locations And Subsidiaries 34
Head Office 34
Other Locations & Subsidiaries 34
Recent Developments 36
Strategy And Business Planning 36
May 20, 2018: GC Pharma to Establish Curevo – a Seattle-based New Company Dedicated to Development of New Vaccines 36
Apr 29, 2017: Green Cross to Build Cell Therapy Manufacturing Facility in China 37
Financial Announcements 38
Oct 30, 2018: GC Pharma reports Q3 2018 results 38
Jul 31, 2018: GC Pharma Reports Q2 2018 Results 39
Apr 27, 2018: GC Pharma Announces Q1 2018 Results 40
Feb 05, 2018: GC Pharma Reports Full Year 2017 Results 41
Product News 42
01/18/2018: GC Pharma Confirms Phase 2/3 Clinical Trial of New Protein Therapy for Hepatitis B 42
Appendix 43
Methodology 43
About GlobalData 43
Contact Us 43
Disclaimer 43

List of Tables
GC Pharma, Pharmaceuticals & Healthcare, Key Facts, 2017 2
GC Pharma, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
GC Pharma, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
GC Pharma, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
GC Pharma, Deals By Therapy Area, 2012 to YTD 2018 9
GC Pharma, Medical Devices Deals, 2012 to YTD 2018 10
GC Pharma, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Argos Therapeutics Raises US$60 Million In Series E Financing 13
Yuhan to Enter into Agreement with GC Pharma 16
Feldan Therapeutics and Green Cross LabCell Enter into Research Partnership 17
AroCell Enters into Co-Development Agreement with Green Cross Cell 18
Green Cross Cell Forms Joint Venture with Harbin Hou pu Tong tang Biotech 19
Green Cross Cell and ToolGen to Enter into Partnership 20
OGD2 Pharma Enters into Agreement with Green Cross LabCell 21
Oxford BioMedica Enters into Agreement with Green Cross 22
Green Cross Enters into Commercialization Agreement with Nanolek 23
Aquavit Pharma Announces Co-Development Agreement With Green Cross For IBX-001 24
Lee's Pharma Enters into Licensing Agreement with GC Pharma 25
Green Cross Enters into Licensing Agreement with Argos Therapeutics 26
Green Cross LabCell Prices IPO of Shares for USD32 Million 28
Innocell Completes Private Placement Of Shares For US$13 Million 29
Green Cross Cell Raises USD55.3 Million in Private Placement of Convertible Bonds 30
Green Cross Acquires Additional 7.07% Stake In Ildong Pharma From WhanIn Pharma 31
GC Pharma, Key Competitors 32
GC Pharma, Key Employees 33
GC Pharma, Other Locations 34
GC Pharma, Subsidiaries 34

List of Figures
GC Pharma, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
GC Pharma, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
GC Pharma, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
GC Pharma, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
GC Pharma, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
GC Pharma, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
GC Pharma, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
GC Pharma, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
GC Pharma, Medical Devices Deals, 2012 to YTD 2018 10

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ GC Pharma (006280):製薬・医療:M&Aディール及び事業提携情報(GC Pharma (006280) - Pharmaceuticals & Healthcare - Deals and Alliances Profile)]についてメールでお問い合わせはこちらでお願いします。

◆H&Iグローバルリサーチのお客様(例)◆